Ally Bridge Group (Ny) LLC Allakos Inc. Transaction History

Ally Bridge Group (Ny) LLC

  • $141 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023
BUY
$5.66 - $8.42 $136,926 - $203,696
24,192 Added 4.04%
622,364 $5.24 Million
Q3 2022

Nov 14, 2022
BUY
$3.02 - $6.12 $1.81 Million - $3.66 Million
598,172 New
598,172 $3.66 Million

Others Institutions Holding ALLK

# of Institutions
81
Shares Held
66.9M
Call Options Held
47.1K
Put Options Held
1K
View Full List

About Allakos Inc.

ALLK Quotes by TradingView
  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $22.9M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track Ally Bridge Group (Ny) LLC Portfolio

Follow Ally Bridge Group (Ny) LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ally Bridge Group (Ny) LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ally Bridge Group (Ny) LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email